Navigation Links
Grand Challenges in Global Health initiative funds Yale project

Yale has been offered $17 million from the Grand Challenges in Global health initiative to genetically engineer mice with immune systems similar enough to humans to aid in testing the safety and effectiveness of potential vaccines.

Funded by the Bill & Melinda Gates Foundation, the Yale project will be headed by Richard A. Flavell, M.D., Sterling Professor and Chair of Immunobiology at Yale University School of Medicine, and Howard Hughes Medical Institute investigator.

Flavell and his team will study a novel solution to a problem facing many vaccine developers. Some of the most promising vaccines for HIV and a range of other diseases are made from weakened versions of the infectious agent. These cannot be studied in human trials unless researchers are confident that they are safe.

"A big need in the world of vaccine development is the ability to predict whether vaccines for humans are safe and effective," said Flavell. "We are grateful to the Grand Challenges in Global Health Initiative for providing the funds to develop a predictive model system for vaccine testing."

Yale School of Medicine Dean Robert Alpern, M.D., said, "This generous grant from the Grand Challenges in Global Health Initiative provides a boost to Yale's ongoing initiatives in basic science and clinical research. It will advance research on diseases that have an effect on communities worldwide."

The goal of this award is to provide to the research community a suitable model system to test live attenuated vaccines for use in the developing world. Flavell said the mice generated would be made available to the broader scientific community in order to meet the charitable objectives of the Grand Challenges Initiative. Flavell will collaborate with the Institute for Research in Biomedicine in Switzerland and with Regeneron Pharmaceuticals in Tarrytown, New York.

The team will engineer a mouse model in which critical components of the human immune syste m replace the similar regions of the mouse. A new technology developed at the Institute for Research in Biomedicine introduces cells from human umbilical cord blood into mice to establish a human immune system. "Using this technology and the genetic modification of the mouse, we will end up with a reasonably faithful replica of the human immune system," said Flavell.

The project is titled "A Mouse Model to Evaluate Live-Attenuated Vaccine Candidates."


'"/>

Source:Yale University


Related biology news :

1. Measurement Challenges In Detecting Cancer Biomarkers
2. Global analysis of membrane proteins
3. Global warming increases oyster sensitivity to pollution
4. Global study shows all tobacco bad for the heart
5. Global warming may warrant new approaches to ecosystem restoration
6. Global warming may have damaged coral reefs forever
7. Global malaria map key weapon in fight against malaria, scientists say
8. Global changes alter the timing of plant growth, scientists say
9. Global map shows new patterns of extinction risk
10. Global sunscreen has likely thinned, report NASA scientists
11. Global survey of lizards reveals greater abundance of animals on islands than on mainland ecosystems
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/14/2019)... ... January 14, 2019 , ... Join ... (4pm GMT) to hear about key topics in data quality, including:, ... ,     Patient engagement ,     Smartphone and wearable based performance measures , ...
(Date:1/8/2019)... ... January 07, 2019 , ... Join industry experts Julie Peacock, Client Services ... webinar on Thursday, January 17, 2019 at 1pm EST. , This webinar ... the clinical trial process. Featured speakers will also present a case study of a ...
(Date:1/7/2019)... ... January 07, 2019 , ... Franz ... Graph Database technology for Knowledge Graphs solutions, announced that it was recognized by ... . DBTA’s data and information management recognition list includes newer approaches leveraging ...
Breaking Biology News(10 mins):
(Date:1/11/2019)... ... ... Drawing on over 22 years of software development expertise, the live ... some of the key lessons that have driven customer satisfaction with their eClinical suite. ... find out how to ensure that you continue to be able to take advantage ...
(Date:1/8/2019)... DENVER (PRWEB) , ... January 07, 2019 , ... ... comprised of its members into Noninvasix. This represents the second investment AngelMD has ... neonatal mortality and morbidity, Noninvasix is developing a patient monitor to directly, accurately, ...
(Date:1/4/2019)... ... 2019 , ... uBiome, the leader in microbial genomics, will ... January 22-25, 2019 held in Davos-Klosters, Switzerland following their selection as a 2018 ... brings together leaders of global society–the heads and members of more than 100 ...
(Date:12/19/2018)... ... December 19, 2018 , ... ... first rate Stem Cell Training Course in Las Vegas. Training includes facial rejuvenation, ... procedures explode in popularity nationwide for aesthetics, having the training from expert, Board ...
Breaking Biology Technology: